SynthesisThe Canadian journal of urology2026
Diagnostic value of percutaneous sampling in Bosniak III-IV renal cysts: a systematic review and meta-analysis.
Synthesis in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesComplex cystic renal lesions pose a significant diagnostic challenge in the preoperative assessment of malignancy. Although percutaneous renal mass biopsy is well established for solid tumours diagnosis, its role in cystic lesions remains controversial. This systematic review aims to evaluate the diagnostic performance, safety, and clinical impact of percutaneous sampling-fine-needle aspiration (FNA) and core needle biopsy (CNB)-in Bosniak III-IV renal cysts.
methodsA systematic review and meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [International Prospective Register of Systematic Reviews (PROSPERO) ID CRD420251124563]. PubMed/MEDLINE (Medical Literature Analysis and Retrieval System Online), Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and Web of Science were searched (1980-May 2025). Eligible studies included adult patients with Bosniak III-IV cysts undergoing FNA or CNB. Pooled diagnostic estimates were calculated using a bivariate random-effects model.
resultsSeven studies, including 954 patients, met the inclusion criteria. Three studies evaluated FNA, yielding a pooled sensitivity of 59% [95% Confidence Interval (CI): 14-93], specificity of 84% (95% CI: 62-94), and an overall diagnostic performance of 0.84 [Area under the curve (AUC)]. Sensitivity estimates varied widely, whereas specificity was consistently high. Four studies assessed CNB, reporting diagnostic yields between 75% and 81%. Cystic morphology was identified as the strongest independent predictor of non-diagnostic sampling, with odds ratios (OR) up to 13.9. No major complications or cases of tumour seeding were reported across the included studies. Reporting of minor complications was limited and heterogeneous, precluding a pooled analysis.
conclusionsPercutaneous sampling of Bosniak III-IV cystic renal masses is feasible but diagnostically challenging. FNA provides limited value due to high rates of non-diagnostic and false-negative results. CNB achieves higher accuracy, particularly when a solid component is present, and may be considered within a multidisciplinary setting when histological confirmation is likely to influence treatment decisions.
Indexed as
Identifiers
42682044What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.